You are viewing the site in preview mode
Skip to main content
| |
Control group
|
Agonist group
|
Antagonist group
|
|---|
|
Sample size
|
15
|
11
|
15
|
|
Age (years)
|
31.3 ± 2.66
|
30.9 ± 2.91
|
31.0 ± 2.90
|
|
Body mass index
|
22.8 ± 3.46
|
21.3 ± 1.48
|
21.9 ± 3.06
|
|
Stimulation duration (day)
|
/
|
10.8 ± 1.47
|
9.33 ± 0.98*
|
|
Total Gn dose (IU)
|
/
|
2178.41 ± 465.8
|
2125 ± 527.23
|
|
Total Cetrorelex dose (mg)
|
/
|
/
|
1.3 ± 0.25
|
|
E2 on trigger day (pg/ml)
|
241.13 ± 69.55*
|
4180.27 ± 1282.49
|
4095.4 ± 1351.49
|
|
P on trigger day (ng/ml)
|
1.39 ± 0.52
|
1.38 ± 0.42
|
1.24 ± 0.36
|
|
LH on trigger day (U/L)
|
/
|
1.64 ± 0.92
|
2.21 ± 1.57
|
|
Number of oocytes retrieved
|
/
|
10.82 ± 3.06
|
10.2 ± 2.75
|
|
Endometrial thickness on biopsy day (cm)
|
0.86 ± 0.10
|
0.94 ± 0.19
|
0.92 ± 0.17
|
|
P on biopsy day (ng/ml)
|
18.7 ± 4.12
|
19.36 ± 4.56
|
19.97 ± 3.66
|
- Data expressed as mean ± SD, and * P < .05
